Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced o...

gan Brose, Marcia S, Nutting, Christopher M, Sherman, Steven I, Shong, Young Kee, Smit, Johannes WA, Reike, Gerhard, Chung, John, Kalmus, Joachim, Kappeler, Christian, Schlumberger, Martin
Cyhoeddwyd 2011

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

gan Riechelmann, Rachel P., Leite, Luiz S., Bariani, Giovanni M., Glasberg, Joao, Rivelli, Thomas G., da Fonseca, Leonardo Gomes, Nebuloni, Daniela R., Braghiroli, Maria I., Queiroz, Marcelo A., Isejima, Alice M., Kappeler, Christian, Kikuchi, Luciana, Hoff, Paulo M.
Cyhoeddwyd yn Oncologist (2019)

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer

gan Worden, Francis, Fassnacht, Martin, Shi, Yuankai, Hadjieva, Tatiana, Bonichon, Françoise, Gao, Ming, Fugazzola, Laura, Ando, Yuichi, Hasegawa, Yasuhisa, Park, Do Joon, Shong, Young Kee, Smit, Johannes W A, Chung, John, Kappeler, Christian, Meinhardt, Gerold, Schlumberger, Martin, Brose, Marcia S
Cyhoeddwyd yn Endocr Relat Cancer (2015)

Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial

gan Brose, Marcia S, Nutting, Christopher M, Jarzab, Barbara, Elisei, Rossella, Siena, Salvatore, Bastholt, Lars, de la Fouchardiere, Christelle, Pacini, Furio, Paschke, Ralf, KeeShong, Young, Sherman, Steven I, Smit, Johannes WA, Chung, John, Kappeler, Christian, Pena, Carol, Molnár, István, Schlumberger, Martin J
Cyhoeddwyd yn Lancet (2014)

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study

gan Van Cutsem, Eric, Martinelli, Erika, Cascinu, Stefano, Sobrero, Alberto, Banzi, Maria, Seitz, Jean‐François, Barone, Carlo, Ychou, Marc, Peeters, Marc, Brenner, Baruch, Hofheinz, Ralf Dieter, Maiello, Evaristo, André, Thierry, Spallanzani, Andrea, Garcia‐Carbonero, Rocio, Arriaga, Yull E., Verma, Udit, Grothey, Axel, Kappeler, Christian, Miriyala, Ashok, Kalmus, Joachim, Falcone, Alfredo, Zaniboni, Alberto
Cyhoeddwyd yn Oncologist (2018)

Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial

gan Xu, Jianming, Xu, Rui‐Hua, Qin, Shukui, Pan, Hongming, Bai, Yuxian, Chi, Yihebali, Wang, Liwei, Bi, Feng, Cheng, Ying, Liu, Tianshu, Ma, Dong, Shen, Lin, Ba, Yi, Liang, Jun, Wang, Xin, Yau, Thomas C C, Ma, Brigette B, Yeh, Kun‐Huei, Lin, Jen‐Kou, Kappeler, Christian, Shapiro, JoAnn, Kalmus, Joachim, Li, Jin
Cyhoeddwyd yn J Gastroenterol Hepatol (2020)

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib: an international, multicentre, prospective, randomised, pl...

gan Demetri, George D, Reichardt, Peter, Kang, Yoon-Koo, Blay, Jean-Yves, Rutkowski, Piotr, Gelderblom, Hans, Hohenberger, Peter, Leahy, Michael, von Mehren, Margaret, Joensuu, Heikki, Badalamenti, Giuseppe, Blackstein, Martin, Cesne, Axel Le, Schöffski, Patrick, Maki, Robert G, Bauer, Sebastian, Nguyen, Binh Bui, Xu, Jianming, Nishida, Toshirou, Chung, John, Kappeler, Christian, Kuss, Iris, Laurent, Dirk, Casali, Paolo
Cyhoeddwyd 2012